Evidence map›Paper›PMID 31300095›Full record

ReviewSeminars in nephrology2019

Acid Base Balance and Progression of Kidney Disease.

Wei Chen, David S Levy, Matthew K Abramowitz

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A Urine pH-Ammonium Acid/Base Score and CKD Progression.Journal of the American Society of Nephrology : JASN · 2024
    Article
  6. Metabolic acidosis in chronic kidney disease: mere consequence or also culprit?Pflugers Archiv : European journal of physiology · 2024
    Review
  7. Article
  8. Article
  9. Metabolic acidosis in pediatric kidney transplant recipients.Pediatric nephrology (Berlin, Germany) · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Evidence for disordered acid-base handling in calcium stone-forming patients.American journal of physiology. Renal physiology · 2020
    Article
  16. Advances in management of chronic metabolic acidosis in chronic kidney disease.Current opinion in nephrology and hypertension · 2019
    Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Wei ChenDepartment of Medicine, Nephrology Division, Albert Einstein College of Medicine, Bronx, NY; Department of Medicine, Nephrology Division, University of Rochester School of Medicine and Dentistry, Rochester, NY. Electronic address: weichen@montefiore.org.
David S LevyDepartment of Medicine, Nephrology Division, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Matthew K AbramowitzDepartment of Medicine, Nephrology Division, Albert Einstein College of Medicine, Bronx, NY.
University of Rochester · USAlbert Einstein College of Medicine · US

Funding

Calcification Propensity, using Dynamic Light Scattering, to Study Vascular Calcification in Patients with Advanced Chronic Kidney DiseaseK23DK114476 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CHEN, WEI · 2018 to 2021
$953k
Inflammation, muscle wasting, and physical function in chronic kidney diseaseK23DK099438 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ABRAMOWITZ, MATTHEW K · 2014 to 2018
$946k
Characterization and novel imaging of skeletal muscle fibrosis in patients with chronic kidney diseaseR03DK116023 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ABRAMOWITZ, MATTHEW K · 2018 to 2019
$182k
NIDDK NIH HHS K23 DK099438NIDDK NIH HHS K23 DK114476NIDDK NIH HHS R03 DK116023
6 · The paper itself

Abstract

A large body of work in animals and human beings supports the hypothesis that metabolic acidosis has a deleterious effect on the progression of kidney disease. Alkali therapy, whether pharmacologically or through dietary intervention, appears to slow CKD progression, but an appropriately powered randomized controlled trial with a low risk of bias is required to reach a more definitive conclusion. Recent work on urinary ammonium excretion has shown that the development of prognostic tools related to acidosis is not straightforward, and that application of urine markers such as ammonium may require more nuance than would be predicted based on our understanding of the pathophysiology.

Indexed as

AcidosisAmmoniaAnimalsBiomarkersDisease ProgressionHumansKidney DiseasesAmmoniaBiomarkersacidosisalkali therapyalkalosischronickidney disease progressionRenal insufficiency

Identifiers

PMID31300095
PMCPMC6629436
OpenAlexW2957385140

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.